Hofseth Biocare ASA (HBC) — Long-term Investment Intensity

Latest as of December 2019: 0.6%

Hofseth Biocare ASA (HBC) has a Long-term Investment Intensity of 0.6% as of December 2019. Long-term investments of Nkr1.73 Million represent 0.6% of total assets of Nkr293.01 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See HBC net asset value for net asset value and shareholders' equity analysis.

LT Investment Intensity

0.6%
LT Investments / Total Assets

Long-term Investments

Nkr1.73 Million
NOK

Total Assets

Nkr293.01 Million
NOK

Country

Norway
OL

Hofseth Biocare ASA Long-term Investment Intensity (2014–2019)

This chart shows how Hofseth Biocare ASA's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 0.6%, reflecting long-term investments of Nkr1.73 Million against total assets of Nkr293.01 Million NOK. Also explore Hofseth Biocare ASA balance sheet assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Hofseth Biocare ASA (2014–2019)

The table below presents the year-by-year Long-term Investment Intensity for Hofseth Biocare ASA from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Hofseth Biocare ASA stock valuation.

Year LT Investment Intensity LT Investments (NOK) Total Assets Change (pp)
2019 0.6% Nkr1.73 Million Nkr293.01 Million ▼ -1.0 pp
2018 1.5% Nkr2.91 Million Nkr187.94 Million ▼ -0.4 pp
2017 2.0% Nkr3.65 Million Nkr184.24 Million ▲ +1.4 pp
2016 0.6% Nkr960.00K Nkr159.35 Million ▼ -0.1 pp
2015 0.7% Nkr1.44 Million Nkr193.35 Million ▲ +0.3 pp
2014 0.4% Nkr886.00K Nkr217.87 Million
pp = percentage points